| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $179.5M | -0.9% | +6.5% |
| Cost of Revenue | $34.3M | -16.1% | -11.8% |
| R&D Expense | $26.0M | -7.9% | +35.9% |
| SG&A Expense | $91.8M | +3.6% | +23.5% |
| Operating Income | $6.4M | -25.1% | +104.6% |
| Interest Expense | $4.3M | -8.9% | -8.7% |
| Pre-tax Income | $9.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $147.6M | -50.9% | -40.0% |
| Short-term Investments | $98.7M | -32.1% | -52.5% |
| Accounts Receivable | $115.3M | +0.8% | +14.5% |
| Inventory | $157.7M | +6.4% | +41.0% |
| Current Assets | $562.8M | -24.5% | -18.4% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $108.3M | — | — |
| Capital Expenditures | $15.1M | — | — |
| Investing Cash Flow | $80.1M | — | — |
| Financing Cash Flow | -$318.0M | — | — |
| Free Cash Flow | $93.2M | — | — |
| +594.2% |
| +106.9% |
| Income Tax | $4.1M | +40.1% | -11.2% |
| Net Income | $5.4M | +212.1% | +103.8% |
| EPS (Basic) | $0.12 | +209.1% | +103.9% |
| EPS (Diluted) | $0.12 | +209.1% | +103.9% |
| $1.30B |
| -15.6% |
| -14.7% |
| Current Liabilities | $107.1M | -65.8% | -65.1% |
| Long-term Debt | $376.7M | -35.1% | — |
| Total Liabilities | $570.4M | -26.8% | -26.1% |
| Stockholders' Equity | $727.2M | -4.0% | -3.0% |